Publikationen

Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective

Umberto Malapelle 1 , Marcello Tiseo 2 , Ana Vivancos 3, Joshua Kapp 4, M. Josè Serrano 5,6,7, and Markus Tiemann 8,*. Liquid Biopsy for Biomarker Testing in Non-Small Cell Lung Cancer: A European Perspective. Molecular Pathology in Solid Tumors. 2021

Morbus Castleman – ein seltenes, heterogenes Krankheitsbild

C. Hoffmann, J.Tepel, M. Tiemann. Morbus Castleman – ein seltenes, heterogenes Krankheitsbild. Best Practice Onkologie 2021

Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping

Fehr A. et al. Mucoepidermoid carcinoma of the salivary glands revisited with special reference to histologic grading and CRTC1/3-MAML2 genotyping. Virchows Arch. 2021 Nov;479(5):975-985. doi: 10.1007/s00428-021-03146-x. Epub 2021 Jul 7. PMID: 34231055

Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy

Jóri, B.; Schatz, S.; Kaller, L.; Kah, B.; Roeper, J.; Ramdani, H.O.; Diehl, L.; Hoffknecht, P.; Grohé, C.; Griesinger, F.; Tiemann, M.; Heukamp, L.C.; Falk, M. Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy. Cancers 2021, 13(12), 2861

BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy

BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapy. European Journal of Cancer 2021; DOI: 10.1016/j.ejca.2021.02.036

Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis

Dmitri Atiakshin  1   2 , Igor Buchwalow  3 , Peter Horny  4 , Markus Tiemann  5. Protease profile of normal and neoplastic mast cells in the human bone marrow with special emphasis on systemic mastocytosis. Histochem Cell Biol. 2021 May;155(5):561-580. doi: 10.1007/s00418-021-01964-3. Epub 2021 Jan 25. PMID: 33492488

Risk stratification of EGFR + lung cancer diagnosed with panel-based next-generation sequencing

Christopoulos P et al. Risk stratification of EGFR + lung cancer diagnosed with panel-based next-generation sequencing. Lung Cancer 2020; Oct;148:105-112. doi: 10.1016/j.lungcan.2020.08.007

to top icon